Top 50 in global drug sales, I'm embarrassed to call it "heavyweight drug" if it's less than $2 billion

Source: according to the heavy drug standard of annual sales of US $1 billion, more than 100 drugs reached the standard in 2014, including US $2.183 billion for top 50 and US $1.643 billion for top 50 in 2013 Before 2014, when it comes to heavy ammunition, the first thing we think about is Lipitor (atorvastatin calcium), enli (enacept), lik, avidin and Herceptin Recently, the website of Pharmaceutical Market Europe (PME) released the world's top 50 heavyweight drugs ranking The number one drug was Humira produced by Albright and Weicai The sales volume in 2014 was US $13.021 billion, up 17% from 2013 Geely's hepatitis C drugs, sovaldi and harvoni, became the third place in the sales of heavyweight drugs in 2014 In 2014 alone, the sales reached 12.41 billion US dollars, far higher than the 139 million US dollars just listed in 2013 The following is the top 50 list of drug sales in 2014 compiled by bio exploration At No 50 on the list this year is lovenox, which is produced by Sanofi to treat anticoagulation, with annual sales of $2.183 billion The success of blockbuster drugs (drugs with annual sales of more than US $1 billion) can be attributed to the following five reasons: 1 Drug efficiency is the basis of blockbuster drugs; 2 Scientific and technological innovation is the core of blockbuster drug development; 3 Follow-up research is an important guarantee for blockbuster drug maturity; 4 Market cultivation is the basic condition for the development of blockbuster drugs 5 Patent protection is the key to blockbuster drug monopoly